Abstract
This case highlights the importance of recognizing and managing CIIHA promptly to achieve a favorable outcome. It is crucial to consider CIIHA in the differential diagnosis of hemolytic anemia in pediatric patients receiving ceftriaxone and to have a high degree of suspicion in cases of unexplained hemolysis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have